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Abstract
Background: In spite of numerous research efforts on supporting the therapy of
diabetes mellitus, the subject still involves challenges and creates active interest
among researchers. In this paper, a decision support tool is presented for setting insulin
therapy in new-onset type 1 diabetes.
Methods: The concept of differential sequential patterns (DSPs) is introduced with the
aim of representing deviations in the patient’s blood glucose level (BGL) and the
amount of insulin injections administered. The decision support tool is created using
data mining algorithms for discovering sequential patterns.
Results: By using the DSPs, it is possible to support the physician’s decisionmaking
concerning changing the treatment (i.e., whether to increase or decrease the insulin
dosage). The other contributions of the paper are an algorithm for generating DSPs
and a new method for evaluating nocturnal glycaemia. The proposed qualitative
evaluation of nocturnal glycaemia improves the generalization capabilities of the DSPs.
Conclusions: The usefulness of the proposed approach was evident in the results of
experiments in which juvenile diabetic patients actual data were used. It was
confirmed that the proposed DSPs can be used to guide the therapy of numerous
juvenile patients with type 1 diabetes.
Keywords: Data mining, Medical patterns, Diabetes mellitus
Introduction
In recent years, the number of cases of diabetes mellitus has increased significantly [1].
Therefore, controlling the concentration of glucose in the patient’s blood is still an impor-
tant problem that is being investigated by many researchers. The problem is a challenge
since the strict medical procedure for controlling BGL cannot be defined [2]. The main
reason is the high variability between people and the numerous different initial clinical
states of patients after they are admitted to the hospital. This especially concerns the
onset of diabetes, when the patient’s state is unstable. For that reason, the existing medical
approach to determining the appropriate therapy is based almost exclusively on the physi-
cian’s experience [3]. Researches has been focused mainly on the so called issue of ’closing
the loop’ [4]. The idea is to create a system that can simulate the pancreas by automatic
adjustment of insulin injections or, in some cases, by delivering glucagon to achieve the
appropriate glucose level. The problem often requires building a decision-support system
based on the prediction of the level of blood glucose.
© 2015 Deja et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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In this paper, we propose a decision support tool for setting basal insulin therapy at
the onset of type 1 diabetes. The proposed method is based on the concept of sequential
patterns [5]. After determining the sequential patterns that underlie a given sequence
of terms, it is possible to predict the plausible continuation of the sequence. From the
medical perspective, sequential patterns can be treated as medical guidelines [3,6,7]. The
advantage of using medical guidelines based on sequential patterns is that they are easy
for physicians to interpret [8].
The concept of sequential patterns has been used extensively in different application
domains [9], especially in medicine [10-12]. Sequential patterns have been used to iden-
tify diagnoses that diverse hospitals have in common [13] or to determine the subsets of
examinations that were done together and that were followed by patients [14]. Several
algorithms to discover sequential patterns have been proposed [5,15]. The concept of
mining diabetes data using sequential patterns first was proposed in [16]. The patterns
that were discovered were used to construct a decision tree that expressed the possible
flow of medical events. Recently, [17] proposed the use of sequential patterns for planning
diabetic therapy. The template-based patterns discovered from historical data were used
to recommend the insulin dosage on the basis of the known value of the level of blood
glucose [17].
One of the limitations of the approach proposed in [17] is the low generalization
capability of the patterns that were discovered over the population of all patients. For
that reason, the patterns were mined and used separately for each individual patient. In
this paper, we describe our effort to extend the application of sequential patterns for
supporting diabetic therapy by increasing their generalization capabilities. It is neces-
sary to mention that such generalization is quite difficult for pre-meal insulin dosage,
because each patient starts a meal with different BGL, and the measurement of the energy
value of the meal is highly imprecise. For that reason, we left that challenge for future
researches and focused our investigation in this research on mining patterns concerning
only long-lasting basal insulin.
The contributions of this paper are as follows:
• A new approach for the qualitative evaluation of nocturnal glycaemia is introduced.
• The concept of differential sequential patterns and an algorithm for mining them are
proposed.
• A decision support tool is developed based on differential sequential patterns. The
decision tool’s output serves as a medical guideline for physicians when, the proper
course of therapy must be determined quickly, e.g., for patients admitted to the
hospital - new-onset diabetes.
The remainder of the paper is organized in the following way. We start with
the Medical background section where the therapy of diabetes is presented. The
basics of sequential patterns are given in Methods section, where later on the con-
tribution of this paper is presented. First, the procedure of qualitative evaluation
of nocturnal glycaemia is formalized. Second, the concept of differential sequences
is introduced, and an algorithm for the generation of sequential patterns based on
differential sequences is proposed. The validation of the proposed approach and the
discussion of the results that were obtained are described in Results of experiments
section.
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Medical background
The main goal of effective diabetes treatment is to maintain the state of near normo-
glyceamia. It is said that the normal glucose level should range between 70-140 mg/dl
throughout the day, although the recommended range before a meal is 70-100 mg/dl
[3]. Therefore repeated measurements of blood glucose during the day are performed
[6]. Typically, the onset of type 1 diabetes among children is rapid, and such patients
should be hospitalized. The initial daily insulin dosage is prescribed based on several basic
data (e.g. the patient’s weight, gender and age), some test results (initial glicaemia level,
acid-base balance, CRP, C-peptyd and HbA1c) and the proposed diet (patient’s energy
demand). Currently, there is no strict medical procedure that allows immediately setting
the proper insulin dosage based on the data listed above. Thus, in the following days, the
daily glucose profile is taken, and the insulin dosage is adaptively modified. The daily glu-
cose profile consists of glicaemia measurements every 2-3 hours during the night, fasting,
before each meal, and 2 hours after each meal. The patient is released from the hospi-
tal when treatment is established, so that during the day, the blood glucose level is close
to normal.
The overall daily insulin dosage is divided with 30% of the dosage administered as the
basal dosage and 70% administered as the pre-meal insulin dosage. (Every patient with
type 1 diabetes mellitus should take two types of insulin.) For the basal insulin the long-
lasting (e.g., glargina insulin) is used. It is a biosynthetic recombinant analog insulin, that
provides 24 hours of continuous activity, becomes fully acting as soon as 2 hours after
administration, and is peakless. The basal insulin is usually injected in the evening (one
injection per day), and it ensures the correct level of glucose during the night and before
meals. In the following days, the results of current measurements of glucose are used
to determine the dosage. The dose for the next day can be reduced when hypoglycemia
occurred in the previous day, or it can be increased id hyperglycemia is observed in the
glucose profile. In the case of increasing the glucose level (more than 200 mg/dl) dur-
ing the night, the short acting insulin is administered immediately as the so-called ’basal
correction’.
The second part of the therapy involves administering pre-meal insulin which, is short
acting. This insulin is served just before each meal - usually 4-5 times a day.
Below, we provide example data concerning dosages of basal insulin and measurements
of the levels of glucose in the blood. These data were collected during two exemplary
days of a patient’s stay in the pediatric, endocrinology, and diabetology clinical hospital
in Katowice, Poland. The data (Table 1) consist of the basal insulin dosage administered
at 10 P.M. and four measurements of blood glucose level during the night (at 0:00, 3:00,
5:00, and 7:00 A.M.).
The nocturnal blood glucose level was interpreted in accordance with accepted med-
ical standards [3] in the following way: when BGL is less than 70 mg/dl, it is treated as
below normal; the normal level is between 70 and 140 mg/dl; the higher level (called
mild-hyperglycemia) is recognized in the range of 140-200 mg/dl; and hyperglycemia is
observed above 200 mg/dl. Thus, the corresponding symbolic values for the discretized
glycaemia attribute are presented in Table 2.
When planning therapy, the physician considers the patient’s clinical status and some
test results [3], but the most important factor when the insulin dosage is initially specified
is the patient’s weight. We used this indication such that the given basal insulin dosage is
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Table 1 Exemplary clinical data
Patient Date Time[h] Value Description
425 2008-11-26 22 10 Basal insulin
425 2008-11-27 0 109 Glycaemia
425 2008-11-27 3 62 Glycaemia
425 2008-11-27 5 60 Glycaemia
425 2008-11-27 7 71 Glycaemia
425 2008-11-27 22 9 Basal insulin
425 2008-11-28 0 114 Glycaemia
425 2008-11-28 3 112 Glycaemia
425 2008-11-28 5 105 Glycaemia
425 2008-11-28 7 99 Glycaemia
425 2008-11-29 22 8 Basal insulin
recalculated into units per 10 kg of the patient’s weight. For example, when considering
the first day of therapy for patient 425, the basal insulin dosage is 10 units, and the patient’s
weight is 32 kg. Thus, in our research the considered/normalized basal insulin dosage was
rounded to 3 units per 10 kg.
Methods
In this section, step-by-step we describe the way the decision support tool for therapy
setting was created. We start with preliminaries about the notion of sequential patterns.
The basics of sequential patterns
Let E = {e1, e2, . . . , en} denote the set of items (also called elements or events). Any subset
of items ai ⊆ E is called an itemset. The sequence a = 〈a1, a2, . . . , ak〉 is defined as
an ordered list of itemsets ai. The term k-sequence denotes any sequence of cardinality
k = card(a), where k is the number of itemsets it contains. The particular item ej ∈ E
may recur in the k-sequence by being included in several itemsets ai.
The sequence a = 〈a1, a2, . . . , an〉 is contained [5] in the other sequence b =
〈b1, b2, . . . , bm〉, i.e. a ⊆ b if there exist integer numbers i1, i2, . . . , in such that a1 ⊆
bi1 , a2 ⊆ bi2 , . . . , an ⊆ bin [5]. The sequence a is called a subsequence of b, and the
sequence b is called a supersequence of a.
Suppose the collection of sequences S = {s1, s2, . . . , sm} is available, where sj =〈
sj1, s
j




denotes the jth sequence consisting of sji itemsets. The support (1) of
sequence a is a fraction of sequences in S that contain a.
sup(a) = card
(
sj ∈ S|a ⊆ sj)
card(S) (1)
Table 2 Glycaemia discretisation
Blood glucose level [mg/dl] Interpretation Discrete value
<70 Hypoglycemia 1
[70, 140) Normoglycemia 2
[140, 200] Mild-hyperglycemia 3
>200 Hyperglycemia 4
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The objective is to determine such subsequences a ⊆ sj that are frequently contained in
any sequences from S , i.e., with the support sup(a) ≥ supmin, where supmin is a threshold
given by experts. Such sequences are in fact a kind of patterns in data, therefore they are
called frequent patterns.
Several algorithms for mining frequent patterns have been proposed, the first and
best known among them being AprioriAll and AprioriSome [5]. The goal of the other
algorithms was to decrease the computational cost of mining [18-20]. An overview of
sequential patterns mining algorithms is available in [21].
Qualitative estimation of nocturnal glycaemia
In the case of the hospital for diabetic children that was considered, the measurements of
BGL are made at 0:00, 3:00, 5:00 and 7:00 A.M. After numerous experiments, it became
clear that the application of the arithmetic mean of four numerical measurements [17]
was not fully correct and led to decreased support for the patterns that were discov-
ered from the sequences stored as historical data. For that reason, we proposed a new
approach.
In fact, qualitative evaluation of nocturnal glycaemia is usually done by doctors to esti-
mate the level of glycamia during the night, and, further, it is used to determine the
basal insulin dosage that is administered on the same day at 22:00 P.M. Formally, let
us denote the sequence of BGL measurements at 0:00, 3:00, 5:00 and 7:00 as bgl =
〈bgl0, bgl3, bgl5, bgl7〉, where bglk is a discrete value of the blood glucose level measured
at time k ∈ {0:00, 3:00, 5:00, 7:00}. Using that sequence, it is proposed that the level of




normoglycemia ⇔ ∀k(bglk = normoglycemia)
hypoglycemia ⇔ ∃k(bglk = hypoglycemia)
hyperglycemia ⇔ ∃k(bglk = hyperglycemia) ∧ ∀k(bglk = hypoglycemia)
mild − hyperglycemia otherwise
Table 3 illustrates the exemplary data given previously in Table 1 after the qualita-
tive evaluation of nocturnal glycaemia. The qualitative evaluation is made in the column
‘Evaluation’, without any changes in the numerical values of the insulin dosage.
Differential sequential patterns
Let us define an ordered pair si = 〈zi, ci〉, where zi denotes the value of basal
insulin dosage, and ci is the value of nocturnal BGL. In this way every sequence
Table 3 Exemplary clinical data after the qualitative evaluation of nocturnal glycaemia
Patient Date Time Evaluation Description
425 2008-11-26 22 3 Basal insulin
425 2008-11-27 Night Hypoglycemia Glycaemia
425 2008-11-27 22 3 Basal insulin
425 2008-11-28 Night Normoglycemia Glycaemia
425 2008-11-28 22 3 Basal insulin
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sj = 〈s1, s2, . . . , sn〉 is related to the basal-insulin therapy of the jth patient. Every
itemset within such sequence is, in fact, an ordered pair of events related to a sin-
gle day of therapy. The goal of the therapy is to discover frequent patterns p ⊂
sj, j ∈[ 1, n] that with high probability will recur for a newly-admitted patient, i.e.,
p ⊂ sn+1.
As stated in Medical background, the basal-insuline therapy is often considered by
physicians in terms of deviations of glycaemia and corresponding insulin dosages. To
reflect this procedure, let us assume that the insulin dosage and the glycaemia level
are denoted as a and b, respectively, at the day of patient’s admission; in this way,
s1 = 〈a, b〉, where a and b are constants. The following insulin dosage (the next day)
can be raised (denoted as ’+’), reduced (denoted as ’-’), or it can be kept at same level





− , for: zi < zi−1
0 , for: zi = zi−1




− , for: ci < ci−1
0 , for: ci = ci−1
+ , for: ci > ci−1
To represent the therapy of a patient, we redefine a differential sequence as
S = 〈s1, s2, . . . , sn〉, where si = 〈di, gi〉. For example, the sequence S =
〈〈3, 3〉, 〈3, 2〉, 〈3, 1〉, 〈2, 2〉〉 is converted to the differential sequence D = 〈〈a, b〉, 〈0,−〉,
〈0,−〉, 〈−,+〉〉 or shorter when omitting bracketsD = 〈a, b, d0, g−, d0, g−, d−, g+〉 - note
that d stands for insulin dosage and g for glycaemia.
The standard support measure given by formula (1) is used for the evaluation of DSP.
Discovering DSP from historical data
In this section an algorithm for mining DSP is proposed. The goal of the mining algorithm
is to determine the set of differential patterns with the given support level. The input
data for the algorithm are the set of differential sequences S prepared by pre-processing
the clinical data gathered and interpreted according to description given in Qualitative
estimation of nocturnal glycaemia.
First, the initial pattern candidate ak is initiated with the itemset < d0, g0 > from the
first sequence from the set S. The support of the candidate pattern for each sequence in
the set S is evaluated. Then, the pattern is enhanced with the following itemset < dj, gj >
of the considered sequence, creating a new candidate pattern. The support of the new
candidate pattern is evaluated, and the algorithm repeats. The loop is ended if the support
of the candidate pattern is less than the given level psupmin or if there are nomore itemsets
in the sequence. The patterns with the support above psupmin and having the required
length (here ≥ 6) are stored. The steps described above are repeated for each unique
sequence from S.
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Algorithm 1: Discovery of differential sequential patterns
input : S = {s1, s2, . . . , sn} the set of patients’ source differential sequences, psupmin -
the acceptable support level
output: A = {a1, a2, . . . , am} the set of patterns
A ← ∅;
foreach si ∈ S do
ak ← ∅;
count(ak) ← 0;
foreach < dj, gj >∈ si do
ak ← ak+ < dj, gj > ;
if ak /∈ A then
foreach sl ∈ S do
if ak ⊆ sl then
count(ak) ← count(ak) + 1 ;
end
end
if count(ak)/n > psupmin and card(ak) ≥ 6 then








The algorithm presented above (Algorithm 1) is based on the AprioriAll [5] sequen-
tial patterns discovery algorithm. There are many different variations of this algorithm
implementation for different purposes with the task to reduce the time andmemory com-
putation complexity [22-24]. The algorithm above has been implemented by authors with
worst time complexity not greater than O(n · k2) where n is the number of sequences and
k is the average length of the sequences.
Decision support
The main application of the mined DSPs is to support setting the therapy for a newly-
admitted diabetic patient. The main idea of that support is to help the physician with
the decision of changing the current treatment (increase or decrease the insulin dosage).
That decision can be made with greater certainty by considering the knowledge gathered
from similar cases presented in the form of differential patterns. In this way, the proposed
supporting tool relies on the set of the mined differential patterns. The following steps
lead the physician in determining the appropriate treatment for the patient:
1. The patient is admitted to the hospital cared for by the physician during a certain
initial period (1-3 days)
Deja et al. BioMedical Engineering OnLine  (2015) 14:13 Page 8 of 11
2. The clinical data of the patient gathered during that initial period are converted
into the form of differential sequence aj (as described in this Section).
3. The computer program retrieves a subset of the patterns S ⊆ P from the set of all
available DSPs such that aj is supported by each sequence from S, i.e.,
S = {s : aj ⊆ s ∧ s ∈ P}. This set is called a set of treatment support patterns (TSP).
4. The selected patterns serve as the medical guidelines for the physician, supporting
her or his decision regarding the following therapy.
After the patient’s hospitalization ends, all of the gathered data are added in the form
of differential sequences to the set of all sequences and the algorithm for mining DSPs is
run again.
Results of experiments
The objective of the following experiments was to validate the theoretical approach pro-
posed in this paper. We used the data of 102 children with onset of type 1 diabetes
collected by the Department of Pediatrics, Endocrinology and Diabetology at the Silesian
Medical University in Katowice, Poland. First, the data were processed, i.e., the discretiza-
tion of BGL and insulin values was performed as described in Medical background.
Afterwards the qualitative evaluation of nocturnal glycaemia was made.
The goal of the first experiment was to mine DSPs from the entire available dataset.
By measuring the support, it was possible to check the generalization capabilities of the
proposed DSP-based model over the set of all patients. The results are given in Table 4.
Table 4 shows that the support of individual DSPs reached quite high values. After
adding the support of the first three patterns that refer to alternative versions of therapy
for the initial three steps, the cumulative support (0.39 + 0.24 + 0.23) = 0.86 was evalu-
ated as high. This means that applying only three of the most general DSPs, it is possible
to propose the therapy for 86% of the patients.
The objective of the second experiment was the evaluation of the usefulness of the
mined DSPs for newly-admitted patients, and 5-fold cross validation with random sam-
pling was applied. The set of patients’ sequences was partitioned into five parts. In each
trial, the selected part served as the testing set, and the rest of sequences constituted
the learning set. Differential patterns were mined from the learning set, and, then, their
support in the testing set was calculated. The results of the experiment are presented in
Tables 5 and 6.
Table 4 The set of DSPsmined from the entire set of data
DSP Supp
〈a, b, d0, g0, d0〉 0.39
〈a, b, d0, g−, d−〉 0.24
〈a, b, d0, g+, d0〉 0.23
〈a, b, d0, g0, d0, g0〉 0.16
〈a, b, d0, g0, d0, g−〉 0.15
〈a, b, d0, g0, d0, g0, d0〉 0.13
〈a, b, d0, g0, d0, g−, d0〉 0.13
〈a, b, d0, g−, d0, g0〉 0.13
〈a, b, d0, g+, d0, g0〉 0.13
〈a, b, d0, g−, d−, g+〉 0.11
〈a, b, d0, g−, d0, g+〉 0.11
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Table 5 Differential patterns, the results of 5-folded cross validation
1st trial Supp 2nd trial Supp
〈a, b, d0, g0, d0〉 0.4 〈a, b, d0, g0, d0〉 0.5
〈a, b, d0, g−, d−〉 0.3 〈a, b, d0, g+, d0〉 0.3
〈a, b, d0, g0, d0, g0, d0〉 0.2 〈a, b, d0, g+, d0, g0〉 0.25
〈a, b, d0, g0, d0, g−〉 0.2 〈a, b, d0, g−, d−〉 0.2
〈a, b, d0, g0, d0, g−, d0〉 0.2 〈a, b, d0, g0, d0, g−〉 0.15
〈a, b, d0, g0, d0, g0〉 0.2 〈a, b, d0, g−, d−, g0〉 0.15
〈a, b, d0, g+, d0〉 0.15
〈a, b, d−, g−, d+〉 0.15
Similarly, as in previous experiment, the support that was obtained was evaluated as
high. Taking into account the patterns with a minimal support level greater or equal to
0.2 and with the length of 2.5 days or more, the non-empty set of treatment support pat-
terns was deduced in 89% of test examples in each trial. The mined patterns can be used
effectively to support the therapy of newly-admitted patients.
We draw the following medical observations regarding the results that were obtained:
• The correction of the initially-administered insulin dosage is often not needed, e.g.,
the DSP = 〈d0, g0, d0, g0, d0〉 represents that fact.
• The physician is not changing the dose hastily just after one day of observation, e.g.,
DSP = 〈g+, d0〉, 〈g−, d0〉 is used, where g+,g- corresponds to the glycaemia level.
• The physician is trying to reduce the insulin dosage and maintain it at that level even
if the body’s response is not clear, e.g, that is represented by DSP = 〈d0, g−, d−〉.
• Considering the whole set of DSPs, it was apparent that the last dosage is usually the
same as the previous dosage, meaning that the patient is leaving the hospital with the
treatment settled and verified with the previous days.
• Another interesting observation is that the body’s response can change even when
the insulin dosage is not changed, see, e.g. DSP = 〈d0, g−, d0, g+〉.
Conclusions
In this paper, the treatment of onset type 1 diabetes patients was analyzed. It was shown
that the proposed differential sequential patterns for setting the basal insulin dosage can
serve as guidelines for physicians during the day-after-day therapy. Also, by having these
patterns, the physician has the opportunity to foresee the possible consequences of the
prescribed therapy. Differential sequences can help the physician to decide the proper
therapy faster. The usability of the proposed differential sequential patterns and the pro-
posed mining algorithm was verified experimentally using real medical data. The results
that were obtained provide evidence of the usefulness of the proposed approach.
Table 6 Differential sequential patterns mined from every learning trial
3rd trial Supp 4th trial Supp 5th trial Supp
〈a, b, d0, g0, d0〉 0.35 〈a, b, d0, g0, d0〉 0.35 〈a, b, d0, g0, d0〉 0.4
〈a, b, d0, g+, d0〉 0.25 〈a, b, d0, g+, d0〉 0.15 〈a, b, d0, g+, d0〉 0.3
〈a, b, d0, g0, d0, g−〉 0.15 〈a, b, d0, g−, d−, g+, d0〉 0.15 〈a, b, d0, g+, d0, g0〉 0.2
〈a, b, d0, g+, d0, g0〉 0.15 〈a, b, d0, g−, d−, g+〉 0.15 〈a, b, d0, g0, d0, g−, d0〉 0.15
〈a, b, d0, g+, d0, g0, d0〉 0.15 〈a, b, d0, g0, d0, g0〉 0.15 〈a, b, d0, g0, d0, g−〉 0.15
Deja et al. BioMedical Engineering OnLine  (2015) 14:13 Page 10 of 11
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RD participated in the design of the study, performed the experiments and drafted the manuscript. WF also participated
in the design of the study, had a significant impact on the final content of the article. GD helped in gathering data,
structured medical background and helped in interpreting results of experiments. All authors read and approved the
final manuscript.
Authors’ information
Both RD and WF are doctors of computer sciences and engineers. They are mainly interested in the applications of
artificial intelligence, in data mining, classification problems, machine learning. Many of their research concerns medical
problems. GD (MD, PhD) is a specialist in diabetology and pediatrician, experienced with scientific projects and medical
studies concerning diabetes mellitus type 1 in children. The results of the studies of the authors are published in
international journals and presented on international congresses.
Acknowledgements
Authors would like to thanks our colleagues Ms. Ossysek and Mr. Chumiecki for their help in collecting the data.
Author details
1Department of Computer Science, Academy of Business in Dabrowa Gornicza, Cieplaka 1c, Dabrowa Gornicza, Poland.
2Institute of Computer Science, University of Silesia, Bedzinska 39, Sosnowiec, Poland. 3School of Medicine in Katowice,
Department of Pediatrics, Pediatric Endocrinology and Diabetes, Medykow 16, Katowice, Poland.
Received: 2 November 2014 Accepted: 26 January 2015
References
1. WHO. Fact Sheet No. 312. http://www.who.int/mediacentre/factsheets/fs312/en/.
2. Toussi M, Lamy J-B, Toumelin PL, Venot A. Using data mining techniques to explore physicians’ therapeutic
decisions when clinical guidelines do not provide recommendations: methods and example for type 2 diabetes.
BMC Med Inform Decis Mak. 2009;9(1):28.
3. ADA. American diabetes association. Standards Med Care Diabetes-2012 Diabetes Care. 2012;35:11–63.
doi:10.2337/dc12-s011.
4. Shalitin S, Phillip M. Closing the loop: combining insulin pumps and glucose sensors in children with type 1
diabetes mellitus. Pediatr Diabetes. 2006;7:45–9.
5. Agrawal R, Srikant R. Mining sequential patterns In: Yu PS, Chen ALP, editors. ICDE, Proceedings of the Eleventh
International Conference on Data Engineering, March 6-10. Taipei, Taiwan: IEEE Computer Society; 1995. p. 3–14.
6. Bangstad HJ, Danne T, Deeb L, Jarosz-Chobot P, Urakami T, Hanas R. Ispad clinical practice consensus guidelines.
insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2009;12:92–9.
7. Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith G. Ispad clinical practice consensus guidelines.
assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes.
2009;12:71–81.
8. Groot P. Experiences in Quality Checking Medical Guidelines using Formal Methods. In: Proceedings verification and
validation of software systems (VVSS 2007). The Netherlands: Eindhoven: Technische Universiteit Eindhoven; 2007.
p. 164–78.
9. Koper A, Nguyen H. Sequential pattern mining from stream data In: Tang J, King I, Chen L, Wang J, editors.
Advanced Data Mining and Applications. Lecture Notes in Computer Science, vol. 7121. Berlin Heidelberg: Springer;
2011. p. 278–91. doi:10.1007/978-3-642-25856-5_21.
10. Yuliana OY, Rostianingsih S, Budhi GS. Discovering sequential disease patterns in medical databases using freespan
mining approach. In: International conference on advance computer science and information system. Universitas
Indonesia: Faculty of Computer Science; 2009.
11. Alonso F, López-Illescas Á, Martínez L, Montes C, Valente JP. Knowledge discovery using medical data mining. In:
Medical data analysis. Springer; 2002. p. 1–12.
12. Kléma J, Nováková L, Karel F, Stepankova O, Zelezny F. Sequential data mining: A comparative case study in
development of atherosclerosis risk factors. Syst Man Cybernet Part C: Appl Rev IEEE Trans. 2008;38(1):3–15.
13. Concaro S, Sacchi L, Bellazzi R. Temporal data mining methods for the analysis of the ahrq archives. Proc Am Med
Inform Assoc 2007 Annu Symp. 2007.
14. Baralis E, Bruno G, Chiusano S, Domenici VC, Mahoto NA, Petrigni C. Analysis of medical pathways by means of
frequent closed sequences. In: Setchi R, Jordanov I, Howlett RJ, Jain LC, editors. KES (3), Lecture notes in computer
science. vol. 6278. Berlin Heidelberg: Springer; 2010. p. 418–25.
15. Srikant R, Agrawal R. Mining sequential patterns: Generalizations and performance improvements. In: Apers PMG,
Bouzeghoub M, Gardarin G, editors. EDBT, Lecture notes in computer science. vol. 1057. Berlin Heidelberg: Springer;
1996. p. 3–17.
16. Rahaman SB, Shashi M. Sequential mining equips e-health with knowledge for managing diabetes. Int J Inf Process
Manag. 2011;2(3):65–71.
17. Froelich W, Deja R, Deja G. Mining therapeutic patterns from clinical data for juvenile diabetes. Fundamenta
Informaticae. 2013;127(1):513–28.
18. Zaki MJ. Efficient enumeration of frequent sequences. In: 7th Intl. conf. on information and knowledge
management. New York, NY, USA: ACM; 1998. p. 68–75.
Deja et al. BioMedical Engineering OnLine  (2015) 14:13 Page 11 of 11
19. Han J, Pei J, Mortazavi-Asl B, Chen Q, Dayal U, Hsu MC. FreeSpan: frequent pattern-projected sequential pattern
mining. New York, NY, USA: ACM; 2000, pp. 355–59.
20. Cheng H, Yan X, Han J. IncSpan: incremental mining of sequential patterns in large database. In: KDD ’04:
Proceedings of the Tenth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. New
York, NY, USA: ACM; 2004. p. 527–32.
21. Han J, Cheng H, Xin D, Yan X. Frequent pattern mining: current status and future directions. Data Min Knowl
Discov. 2007;15(1):55–86.
22. Cavique L. A network algorithm to discover sequential patterns. In: Progress in artificial intelligence. Berlin
Heidelberg: Springer; 2007. p. 406–14.
23. He D. Using suffix tree to discover complex repetitive patterns in dna sequences. In: Conf Proc IEEE Eng Med Biol
Soc. vol. 1. IEEE; 2006. p. 3474–7.
24. Shakya S, Singh A, Singh D. A time efficient algorithm for web log analysis. Int J Comput Appl. 2013;75(9):23–30.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
